Review: Bladder-sparing Therapy for Bacillus Calmette-Guérin–unresponsive Non–muscle-invasive Bladder Cancer: International Bladder Cancer Group Recommendations for Optimal Sequencing and Patient Selection by Roger Li et al

Read the full Review here: https://buff.ly/3Byem6s

#UroSky

Our first Editor's Choice Article has been chosen by our EiC Alberto Briganti: EAU Guidelines on Non–muscle-invasive Bladder Cancer (TaT1 and Carcinoma In Situ)—A Summary of the 2024 Guidelines Update by Paolo Gontero et al

Read the full article here: buff.ly/3AXFEDi

#UroSky

Platinum Priority: Integrative Drug Screening and Multiomic Characterization of Patient-derived Bladder Cancer Organoids Reveal Novel Molecular Correlates of Gemcitabine Response by N.M. Merrill et al

Full article: https://buff.ly/4i0cxQ7

Check back later for the editorial!
#UroSky #UroSoMe

Review: Improving Patient Information and Enhanced Consent in Urology: The Impact of Simulation and Multimedia Tools. A Systematic Literature Review from the European Association of Urology Patient Office by Carlotta Nedbal et al

Read the full review here: https://buff.ly/3ZeWEOr

#UroSky #UroSoMe

Words of Wisdom Wednesday: Re: Transurethral En Bloc Resection Versus Standard Resection of Bladder Tumour: A Randomised, Multicentre, Phase 3 Trial by Stefano Mancon et al

Check out the summary below and read the full article here: https://buff.ly/4i9UNlJ

#UroSky #UroSoMe #EU #WoWWednesday

Words of Wisdom Wednesday: Re: Complications Following Transrectal and Transperineal Prostate Biopsy: Results of the ProBE-PC Randomized Clinical Trial by @boesenlars.bsky.social and @chapinmd.bsky.social
Check out the summary below and read the full article here: https://buff.ly/4fENr7V
#UroSky

European Urology remains at the top of our field in Nephrology and Urology. With the new IF of 25.3 and over 2 million website downloads we are constantly striving to be a cut above the rest! Thank you to our Authors, Reviewers, and Readership!

#UroSoMe #EU #ImpactFactor